Structure based on 3lpk

Ideal structure
Name: n-[(1s,2s)-1-(3,5-difluorobenzyl)-2-hydroxy-2-{(2r)-4-[(3-methylphenyl)sulfonyl]piperazin-2-yl}ethyl]-3-{[(2r)-2-(methoxymethyl)pyrrolidin-1-yl]carbonyl}-5-methylbenzamide
Formula: C35 H42 F2 N4 O6 S
Weight: 684.793
SMILES: "COC[CH]1CCCN1C(=O)c2cc(C)cc(c2)C(=O)N[CH](Cc3cc(F)cc(F)c3)[CH](O)[CH]4CN(CCN4)[S](=O)(=O)c5cccc(C)c5"
Spacial conformation based on PDB 3lpk
RESIDUE   Z76     90
CONECT      C1     3 C2   C6   H1  
CONECT      F1     1 C21 
CONECT      N1     3 C7   C8   C9  
CONECT      O1     1 C7  
CONECT      S1     4 N4   O6   O7   C40 
CONECT      C2     3 C1   C3   C7  
CONECT      F2     1 C23 
CONECT      N2     3 C15  C16  HN2 
CONECT      O2     1 C15 
CONECT      C3     3 C2   C4   H3  
CONECT      N3     3 C28  C29  HN3 
CONECT      O3     2 C17  HO3 
CONECT      C4     3 C3   C5   C15 
CONECT      N4     3 S1   C25  C27 
CONECT      C5     3 C4   C6   H5  
CONECT      O5     2 C12  C34 
CONECT      C6     3 C1   C5   C14 
CONECT      O6     1 S1  
CONECT      C7     3 N1   O1   C2  
CONECT      O7     1 S1  
CONECT      C8     4 N1   C11  C12  H8  
CONECT      C9     4 N1   C10  H9   H9A 
CONECT      C10    4 C9   C11  H10  H10A
CONECT      C11    4 C8   C10  H11  H11A
CONECT      C12    4 O5   C8   H12  H12A
CONECT      C14    4 C6   H14  H14A H14B
CONECT      C15    3 N2   O2   C4  
CONECT      C16    4 N2   C17  C18  H16 
CONECT      C17    4 O3   C16  C29  H17 
CONECT      C18    4 C16  C19  H18  H18A
CONECT      C19    3 C18  C20  C24 
CONECT      C20    3 C19  C21  H20 
CONECT      C21    3 F1   C20  C22 
CONECT      C22    3 C21  C23  H22 
CONECT      C23    3 F2   C22  C24 
CONECT      C24    3 C19  C23  H24 
CONECT      C25    4 N4   C29  H25  H25A
CONECT      C27    4 N4   C28  H27  H27A
CONECT      C28    4 N3   C27  H28  H28A
CONECT      C29    4 N3   C17  C25  H29 
CONECT      C32    4 C38  H32  H32A H32B
CONECT      C34    4 O5   H34  H34A H34B
CONECT      C35    3 C36  C40  H35 
CONECT      C36    3 C35  C37  H36 
CONECT      C37    3 C36  C38  H37 
CONECT      C38    3 C32  C37  C39 
CONECT      C39    3 C38  C40  H39 
CONECT      C40    3 S1   C35  C39 
CONECT      H1     1 C1  
CONECT      HN2    1 N2  
CONECT      H3     1 C3  
CONECT      HN3    1 N3  
CONECT      HO3    1 O3  
CONECT      H5     1 C5  
CONECT      H8     1 C8  
CONECT      H9     1 C9  
CONECT      H9A    1 C9  
CONECT      H10    1 C10 
CONECT      H10A   1 C10 
CONECT      H11    1 C11 
CONECT      H11A   1 C11 
CONECT      H12    1 C12 
CONECT      H12A   1 C12 
CONECT      H14    1 C14 
CONECT      H14A   1 C14 
CONECT      H14B   1 C14 
CONECT      H16    1 C16 
CONECT      H17    1 C17 
CONECT      H18    1 C18 
CONECT      H18A   1 C18 
CONECT      H20    1 C20 
CONECT      H22    1 C22 
CONECT      H24    1 C24 
CONECT      H25    1 C25 
CONECT      H25A   1 C25 
CONECT      H27    1 C27 
CONECT      H27A   1 C27 
CONECT      H28    1 C28 
CONECT      H28A   1 C28 
CONECT      H29    1 C29 
CONECT      H32    1 C32 
CONECT      H32A   1 C32 
CONECT      H32B   1 C32 
CONECT      H34    1 C34 
CONECT      H34A   1 C34 
CONECT      H34B   1 C34 
CONECT      H35    1 C35 
CONECT      H36    1 C36 
CONECT      H37    1 C37 
CONECT      H39    1 C39 
END   
HET    Z76             90
HETNAM     Z76 N-[(1S,2S)-1-(3,5-difluorobenzyl)-2-hydroxy-2-{(2R)-4-[
HETNAM   2 Z76 (3-methylphenyl)sulfonyl]piperazin-2-yl}ethyl]-3-{[(2R)
HETNAM   3 Z76 -2-(methoxymethyl)pyrrolidin-1-yl]carbonyl}-5-methylben
HETNAM   4 Z76 zamide
FORMUL      Z76    C35 H42 F2 N4 O6 S1

This OCA MONOMER page
uses Jmol, developed by the Jmol Development Team (color reference)
OCA© by Jaime Prilusky, 1996-2004,2006,2010,2014
Bioinformatics Unit
Weizmann Institute of Science